Katayama I, Maruyama K, Fukushima T, Nishibe Y, Kayano H
Department of Pathology, Saitama Medical School, Japan.
Leukemia. 1987 Apr;1(4):401-4.
Sera from 11 Japanese patients with hairy cell leukemia and 4B122, an anti-hairy cell serum produced by the authors, were surveyed by Western blot analyses for cross-reacting antibodies to human T cell leukemia virus (HTLV)-I and -II virions released, respectively, from Lma-66 and Mo-T cell lines. Sera from the majority of the patients showed positive reactions with p15, p19, and/or p24 of HTLV-I and with p21 and/or p22 or HTLV-II. 4B122 was weakly cross-reactive with HTLV-II but not with HTLV-I. These results militate against the involvement of HTLV-I or -II but may implicate a role by a cross-reacting, previously unrecognized retrovirus in the pathogenesis of hairy cell leukemia in Japanese patients.
通过蛋白质印迹分析,对11名日本毛细胞白血病患者的血清以及作者制备的抗毛细胞血清4B122进行检测,以寻找与分别从Lma - 66和Mo - T细胞系释放的人类T细胞白血病病毒(HTLV)-I和-II病毒体发生交叉反应的抗体。大多数患者的血清与HTLV -I的p15、p19和/或p24以及HTLV -II的p21和/或p22呈阳性反应。4B122与HTLV -II有弱交叉反应,但与HTLV -I无交叉反应。这些结果不支持HTLV -I或-II参与其中,但可能暗示一种以前未被认识的交叉反应逆转录病毒在日本患者毛细胞白血病发病机制中起作用。